Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Bone disorders in human immunodeficiency virus infection.

Glesby MJ.

Clin Infect Dis. 2003;37 Suppl 2:S91-5. Review.

2.

[Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].

Olczak A, Pawłowska M, Drózdz W.

Przegl Epidemiol. 2008;62(1):155-62. Review. Polish.

PMID:
18536239
3.
4.

Emerging bone problems in patients infected with human immunodeficiency virus.

Mondy K, Tebas P.

Clin Infect Dis. 2003 Apr 1;36(Suppl 2):S101-5.

5.

Bone mineral abnormalities in persons with HIV infection: signal or noise?

Singh K, Moyle GJ.

AIDS Read. 2006 Aug;16(8):407-10, 413-8. Review.

PMID:
16933375
6.

Osteopenia in patients infected by the human immunodeficiency virus. A case control study.

Loiseau-Pérès S, Delaunay C, Poupon S, Lespessailles E, Ballouche N, Arsac P, Benhamou CL.

Joint Bone Spine. 2002 Oct;69(5):482-5.

PMID:
12477232
7.

Bone disorders, hypertension, and mitochondrial toxicity in HIV disease.

Newman MD.

Top HIV Med. 2003 Jan-Feb;11(1):10-5. Review.

8.

Adverse effects of antiretroviral therapy: focus on bone density.

Viganò A, Mora S.

Expert Opin Drug Saf. 2004 May;3(3):199-208. Review.

PMID:
15155148
9.

Bone disease and HIV infection.

Amorosa V, Tebas P.

Clin Infect Dis. 2006 Jan 1;42(1):108-14. Epub 2005 Nov 30. Review.

10.

Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).

Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, Ragnaud JM, Malvy D, Dupon M, Mercié P, Schaeverbeke T, Haramburu F, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

HIV Med. 2004 Nov;5(6):421-6.

11.

Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.

Monier P, McKown K, Bronze MS.

Clin Infect Dis. 2000 Dec;31(6):1488-92. Epub 2000 Nov 29. Review.

12.

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.

Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

AIDS. 2008 Jan 30;22(3):395-402. doi: 10.1097/QAD.0b013e3282f423dd.

PMID:
18195566
13.

Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.

Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.

Wien Klin Wochenschr. 2007;119(21-22):639-46.

PMID:
18043884
14.

[Bone mineral loss in patients with human immunodeficiency virus infection].

Olmos JM, González-Macías J.

Enferm Infecc Microbiol Clin. 2008 Apr;26(4):212-9. Review. Spanish.

PMID:
18381041
15.

Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.

Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J.

AIDS. 2003 Sep 5;17(13):1917-23.

PMID:
12960824
16.

HIV infection--a risk factor for osteoporosis.

Thomas J, Doherty SM.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):281-91. Review.

PMID:
12843738
17.

The metabolic toxicities of antiretroviral therapy.

Herman JS, Easterbrook PJ.

Int J STD AIDS. 2001 Sep;12(9):555-62; quiz 563-4. Review.

PMID:
11516363
18.

The role of HIV and antiretroviral therapy in bone disease.

Gutiérrez F, Masiá M.

AIDS Rev. 2011 Apr-Jun;13(2):109-18. Review.

PMID:
21587342
19.

Orthopedic illnesses in patients with HIV.

Takhar SS, Hendey GW.

Emerg Med Clin North Am. 2010 May;28(2):335-42, Table of Contents. doi: 10.1016/j.emc.2010.01.009. Review.

PMID:
20413016
20.

[Osteopathies that weaken HIV-infected patients].

Rey D.

Presse Med. 2003 Dec 13;32(39):1857-63. Review. French.

PMID:
14713883
Items per page

Supplemental Content

Write to the Help Desk